ESMA LIBRARY
The ESMA Library contains all ESMA documents. Please use the search and filter options to find specific documents.
47
REFINE YOUR SEARCH
Sections
- (-) Remove COVID-19 filter COVID-19
- (-) Remove Prospectus filter Prospectus
- (-) Remove Sustainable finance filter Sustainable finance
- (-) Remove Management Board filter Management Board
- (-) Remove Guidelines and Technical standards filter Guidelines and Technical standards
- MiFID - Secondary Markets (111) Apply MiFID - Secondary Markets filter
- MiFID - Investor Protection (82) Apply MiFID - Investor Protection filter
- Post Trading (49) Apply Post Trading filter
- Market Integrity (48) Apply Market Integrity filter
- Short Selling (37) Apply Short Selling filter
- Brexit (35) Apply Brexit filter
- Corporate Disclosure (35) Apply Corporate Disclosure filter
- Fund Management (25) Apply Fund Management filter
- Board of Supervisors (22) Apply Board of Supervisors filter
- Corporate Information (22) Apply Corporate Information filter
- Press Releases (22) Apply Press Releases filter
- Credit Rating Agencies (19) Apply Credit Rating Agencies filter
- IFRS Supervisory Convergence (18) Apply IFRS Supervisory Convergence filter
- Joint Committee (16) Apply Joint Committee filter
- Benchmarks (12) Apply Benchmarks filter
- Innovation and Products (12) Apply Innovation and Products filter
- Supervisory convergence (11) Apply Supervisory convergence filter
- Market Abuse (10) Apply Market Abuse filter
- CCP Directorate (7) Apply CCP Directorate filter
- MiFID II: Transparency Calculations and DVC (7) Apply MiFID II: Transparency Calculations and DVC filter
- CESR Archive (6) Apply CESR Archive filter
- Securities Financing Transactions (6) Apply Securities Financing Transactions filter
- Trade Repositories (6) Apply Trade Repositories filter
- Warnings and publications for investors (6) Apply Warnings and publications for investors filter
- Trading (5) Apply Trading filter
- Corporate Governance (4) Apply Corporate Governance filter
- IAS Regulation (4) Apply IAS Regulation filter
- Securitisation (4) Apply Securitisation filter
- Speeches (4) Apply Speeches filter
- Market data (3) Apply Market data filter
- Securities and Markets Stakeholder Group (3) Apply Securities and Markets Stakeholder Group filter
- Corporate Finance (2) Apply Corporate Finance filter
- Risk Analysis & Economics - Markets Infrastructure Investors (2) Apply Risk Analysis & Economics - Markets Infrastructure Investors filter
- Audit (1) Apply Audit filter
- International cooperation (1) Apply International cooperation filter
- Transparency (1) Apply Transparency filter
Type of document
- (-) Remove Statement filter Statement
- (-) Remove Opinion filter Opinion
- Guidelines & Recommendations (560) Apply Guidelines & Recommendations filter
- Reference (97) Apply Reference filter
- Press Release (48) Apply Press Release filter
- Summary of Conclusions (48) Apply Summary of Conclusions filter
- Compliance table (47) Apply Compliance table filter
- Final Report (35) Apply Final Report filter
- Letter (25) Apply Letter filter
- Report (20) Apply Report filter
- Consultation Paper (18) Apply Consultation Paper filter
- Decision (17) Apply Decision filter
- Speech (12) Apply Speech filter
- Q&A (7) Apply Q&A filter
- Annual Report (4) Apply Annual Report filter
- SMSG Advice (4) Apply SMSG Advice filter
- Technical Advice (3) Apply Technical Advice filter
- CESR Document (2) Apply CESR Document filter
- Technical Standards (1) Apply Technical Standards filter
Your filters
Statement X Opinion X Sustainable finance X Management Board X Prospectus X Guidelines and Technical standards X COVID-19 X
Reset all filtersDate | Ref. | Title | Section | Type | Download | Info | Summary | Related Documents | Translated versions |
---|---|---|---|---|---|---|---|---|---|
25/03/2020 | ESMA32-63-951 | Accounting implications of the COVID-19 outbreak on the calculation of expected credit losses in accordance with IFRS 9 | Corporate Disclosure, COVID-19 | Statement | PDF 135.91 KB |
||||
09/04/2020 | ESMA34-45-896 | Actions to mitigate the impact of COVID-19 on the deadlines for the publication of periodic reports by fund managers | COVID-19, Fund Management | Statement | PDF 113.03 KB |
||||
09/04/2020 | ESMA80-187-546 | Actions to mitigate the impact of COVID-19 on the EU financial markets regarding the timeliness of fulfilling external audit requirements for interest rate benchmarks under the Benchmarks Regulation | Benchmarks, COVID-19 | Statement | PDF 89.31 KB |
||||
31/03/2020 | ESMA35-36-1919 | Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28 | COVID-19, MiFID - Investor Protection | Statement | PDF 89.84 KB |
||||
02/06/2022 | JC 2022 23 | Clarifications on the ESAs' draft RTS under SFDR | Joint Committee, Sustainable finance | Statement | PDF 306.38 KB |
||||
26/03/2020 | ESMA80-191-995 | COVID-19 Public Statement | COVID-19, Securities Financing Transactions | Statement | PDF 113.93 KB |
||||
24/03/2021 | ESMA71-99-1608 | ESMA appoints new chair of Market Integrity Standing Committee | Board of Supervisors, Management Board, Market Integrity, Press Releases | Statement | PDF 37.58 KB |
||||
28/01/2021 | ESMA71-99-1544 | ESMA appoints new IPISC and CNS Chairs | Board of Supervisors, Corporate Information, MiFID - Investor Protection, Sustainable finance | Statement | PDF 87.3 KB |
||||
28/01/2021 | ESMA71-99-1544 | ESMA appoints new IPISC and CSN chairs | Board of Supervisors, Corporate Information, MiFID - Investor Protection, Sustainable finance | Statement | |||||
06/07/2017 | ESMA71-99-522 | ESMA appoints new member to its Management Board | Corporate Information, Management Board | Statement | PDF 144.98 KB |
||||
28/01/2021 | ESMA71-99-1545 | ESMA new MB member January 2021 | Board of Supervisors, Corporate Information, Management Board | Statement | PDF 89.41 KB |
||||
09/04/2020 | ESMA70-155-9817 | ESMA postpones the publication dates of the annual transparency calculations for non-equity instruments and for the quarterly systematic internaliser data for non-equity instruments other than bonds | COVID-19, MiFID - Secondary Markets, MiFID II: Transparency Calculations and DVC | Statement | PDF 94.58 KB |
||||
15/07/2021 | ESMA32-384-5209 | ESMA Public Statement SPACs | MiFID - Investor Protection, Prospectus | Statement | PDF 151.59 KB |
||||
11/06/2020 | ESMA32-334-245 | ESMA response to EC Consultation on NFRD | Corporate Disclosure, Sustainable finance | Statement | PDF 429.86 KB |
||||
15/07/2020 | ESMA71-99-1364 | ESMA Statement on Assessment of German Financial Reporting Regime | Corporate Disclosure, Guidelines and Technical standards, Press Releases, Supervisory convergence | Statement | PDF 88.5 KB |
||||
20/03/2020 | ESMA35-43-2348 | ESMA Statement on COVID-19 telephone recording | COVID-19, MiFID - Investor Protection | Statement | PDF 114.12 KB |
||||
11/03/2020 | ESMA71-99-1290 | ESMA Statement on Markets and COVID-19 | Board of Supervisors, COVID-19 | Statement | PDF 87.99 KB |
||||
14/05/2020 | ESMA50-158-2232 | ESMA supports ESRB actions to address COVID-related systemic vulnerabilities | COVID-19, Fund Management | Statement | PDF 81.33 KB |
||||
18/12/2013 | 2013/1944 | Format of the base prospectus and consistent application of Article 26(4) of the Prospectus Regulation | Prospectus, Corporate Disclosure | Opinion | PDF 75.6 KB |
||||
20/03/2013 | 2013/317 | Framework for the assessment of third country prospectuses under Article 20 of the Prospectus Directive | Prospectus, Corporate Disclosure | Opinion | PDF 725.59 KB |